Pathology Analysis & Statistics, November 2014 (p20)

24/7 Customer Support

Talk to Amrita

+1 718 303 2019

Publishers

All regions

You might be interested in: Cancer, Breast Cancer, Leukemia, more »

571-620 of about 4 400 reports

Purchase Reports From Reputable Market Research Publishers

IMMUNOSYN CORPORATION (Symbol:IMYN) SWOT Analysis, Strategy, Revenues and Profits

IMMUNOSYN CORPORATION (Symbol:IMYN) SWOT Analysis, Strategy, Revenues and Profits

  • $ 300
  • Company report
  • November 2014
  • by Global Data

This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in ...

  • Industries : Pathology
  • Countries : United States
Neurobiological Technologies, Inc. (Symbol:NTII) SWOT Analysis, Strategy, Revenues and Profits

Neurobiological Technologies, Inc. (Symbol:NTII) SWOT Analysis, Strategy, Revenues and Profits

  • $ 300
  • Company report
  • November 2014
  • by Global Data

This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in ...

  • Industries : Pathology
  • Countries : United States
NeurogesX, Inc. (Symbol:NGSX) SWOT Analysis, Strategy, Revenues and Profits

NeurogesX, Inc. (Symbol:NGSX) SWOT Analysis, Strategy, Revenues and Profits

  • $ 300
  • Company report
  • November 2014
  • by Global Data

This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in ...

  • Industries : Pathology
  • Countries : United States
Oscotec Inc. (Symbol:039200) SWOT Analysis, Strategy, Revenues and Profits

Oscotec Inc. (Symbol:039200) SWOT Analysis, Strategy, Revenues and Profits

  • $ 300
  • Company report
  • November 2014
  • by Global Data

This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in ...

  • Industries : Pathology
  • Countries : South Korea
Proteonomix, Inc. (PROTE) - Financial and Strategic SWOT Analysis Review

Proteonomix, Inc. (PROTE) - Financial and Strategic SWOT Analysis Review

  • $ 300
  • Company report
  • November 2014
  • by Global Data

Summary Proteonomix, Inc. (Proteonomix) is a biotechnology company. The company develops therapeutics based upon use of human cells and their derivatives for the treatment of diabetes and cardiac diseases. ...

  • Industries : Pathology
  • Countries : United States
Patrys Limited (Symbol:PAB) SWOT Analysis, Strategy, Revenues and Profits

Patrys Limited (Symbol:PAB) SWOT Analysis, Strategy, Revenues and Profits

  • $ 300
  • Company report
  • November 2014
  • by Global Data

This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in ...

  • Industries : Pathology
  • Countries : Australia
PHARMENA SA (Symbol:PHR) SWOT Analysis, Strategy, Revenues and Profits

PHARMENA SA (Symbol:PHR) SWOT Analysis, Strategy, Revenues and Profits

  • $ 300
  • Company report
  • November 2014
  • by Global Data

This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in ...

  • Industries : Pathology
  • Countries : Poland, United States
PhytoHealth Corporation (Symbol:4108) SWOT Analysis, Strategy, Revenues and Profits

PhytoHealth Corporation (Symbol:4108) SWOT Analysis, Strategy, Revenues and Profits

  • $ 300
  • Company report
  • November 2014
  • by Global Data

This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in ...

  • Industries : Pathology
  • Countries : Taiwan
PhytoMedical Technologies, Inc. (Symbol:PYTO) SWOT Analysis, Strategy, Revenues and Profits

PhytoMedical Technologies, Inc. (Symbol:PYTO) SWOT Analysis, Strategy, Revenues and Profits

  • $ 300
  • Company report
  • November 2014
  • by Global Data

This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in ...

  • Industries : Pathology
  • Countries : United States
R-Tech Ueno, Ltd. (Symbol:4573) SWOT Analysis, Strategy, Revenues and Profits

R-Tech Ueno, Ltd. (Symbol:4573) SWOT Analysis, Strategy, Revenues and Profits

  • $ 300
  • Company report
  • November 2014
  • by Global Data

This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in ...

  • Industries : Pathology
Samjin Pharmaceutical Co., Ltd. (Symbol:005500) SWOT Analysis, Strategy, Revenues and Profits

Samjin Pharmaceutical Co., Ltd. (Symbol:005500) SWOT Analysis, Strategy, Revenues and Profits

  • $ 300
  • Company report
  • November 2014
  • by Global Data

This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in ...

  • Industries : Pathology
  • Countries : South Korea
Sanguine Corporation (Symbol:SGUI) SWOT Analysis, Strategy, Revenues and Profits

Sanguine Corporation (Symbol:SGUI) SWOT Analysis, Strategy, Revenues and Profits

  • $ 300
  • Company report
  • November 2014
  • by Global Data

This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in ...

  • Industries : Pathology
  • Countries : United States
Sanwa Kagaku Kenkyusho Co., Ltd. - Strategic SWOT Analysis Review

Sanwa Kagaku Kenkyusho Co., Ltd. - Strategic SWOT Analysis Review

  • $ 300
  • Company report
  • November 2014
  • by Global Data

Summary Sanwa Kagaku Kenkyusho Co., Ltd. (Sanwa Kagaku) is a pharmaceutical company. The company manufactures and markets pharmaceuticals, diagnostics, medical and nursing care nutritionals and healthcare ...

  • Industries : Pathology
  • Countries : Japan
Topsun Science and Technology Co., Ltd. (Symbol:600771) SWOT Analysis, Strategy, Revenues and Profits

Topsun Science and Technology Co., Ltd. (Symbol:600771) SWOT Analysis, Strategy, Revenues and Profits

  • $ 300
  • Company report
  • November 2014
  • by Global Data

This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in ...

  • Industries : Pathology
Clinica Baviera SA (Symbol:CBAV) SWOT Analysis, Strategy, Revenues and Profits

Clinica Baviera SA (Symbol:CBAV) SWOT Analysis, Strategy, Revenues and Profits

  • $ 300
  • Company report
  • November 2014
  • by Global Data

This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in ...

  • Industries : Pathology
  • Countries : Spain
CUREXO, INC. (Symbol:060280) SWOT Analysis, Strategy, Revenues and Profits

CUREXO, INC. (Symbol:060280) SWOT Analysis, Strategy, Revenues and Profits

  • $ 300
  • Company report
  • November 2014
  • by Global Data

This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in ...

  • Industries : Pathology
  • Countries : South Korea
CytoTools AG (Symbol:T5O) SWOT Analysis, Strategy, Revenues and Profits

CytoTools AG (Symbol:T5O) SWOT Analysis, Strategy, Revenues and Profits

  • $ 300
  • Company report
  • November 2014
  • by Global Data

This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in ...

  • Industries : Pathology
  • Countries : Germany
Janssen-Cilag Gmbh SWOT Analysis, Strategy, Revenues and Profits

Janssen-Cilag Gmbh SWOT Analysis, Strategy, Revenues and Profits

  • $ 300
  • Company report
  • November 2014
  • by Global Data

This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in ...

  • Industries : Pathology
  • Countries : Germany
Komipharm International Co., Ltd. (Symbol:041960) SWOT Analysis, Strategy, Revenues and Profits

Komipharm International Co., Ltd. (Symbol:041960) SWOT Analysis, Strategy, Revenues and Profits

  • $ 300
  • Company report
  • November 2014
  • by Global Data

This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in ...

  • Industries : Pathology
  • Countries : Philippines, Sri Lanka, Asia
LVL Medical Groupe SA (Symbol:LVL) SWOT Analysis, Strategy, Revenues and Profits

LVL Medical Groupe SA (Symbol:LVL) SWOT Analysis, Strategy, Revenues and Profits

  • $ 300
  • Company report
  • November 2014
  • by Global Data

This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in ...

  • Industries : Pathology
  • Countries : France
MetrioPharm AG (Symbol:MP5) SWOT Analysis, Strategy, Revenues and Profits

MetrioPharm AG (Symbol:MP5) SWOT Analysis, Strategy, Revenues and Profits

  • $ 300
  • Company report
  • November 2014
  • by Global Data

This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in ...

  • Industries : Pathology
  • Countries : Switzerland
Microbio Co., Ltd. (Symbol:4128) SWOT Analysis, Strategy, Revenues and Profits

Microbio Co., Ltd. (Symbol:4128) SWOT Analysis, Strategy, Revenues and Profits

  • $ 300
  • Company report
  • November 2014
  • by Global Data

This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in ...

  • Industries : Pathology
  • Countries : Taiwan
Solvay Pharma India Ltd. (Symbol:532447) SWOT Analysis, Strategy, Revenues and Profits

Solvay Pharma India Ltd. (Symbol:532447) SWOT Analysis, Strategy, Revenues and Profits

  • $ 300
  • Company report
  • November 2014
  • by Global Data

This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in ...

  • Industries : Pathology
  • Countries : India
Stirling Products Limited (Symbol:STI) SWOT Analysis, Strategy, Revenues and Profits

Stirling Products Limited (Symbol:STI) SWOT Analysis, Strategy, Revenues and Profits

  • $ 300
  • Company report
  • November 2014
  • by Global Data

This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in ...

  • Industries : Pathology
  • Countries : Canada, United States, Australia
Gufic BioSciences Limited (GUFICBIO) - Financial and Strategic SWOT Analysis Review

Gufic BioSciences Limited (GUFICBIO) - Financial and Strategic SWOT Analysis Review

  • $ 300
  • Company report
  • November 2014
  • by Global Data

Summary Gufic BioSciences Limited (Gufic) is a generic pharmaceutical company. It carries out development, manufacturing and marketing of pharmaceutical, generics, herbal, API's and healthcare products. ...

  • Industries : Pathology
Upstream Biosciences Inc. (UPBS) - Financial and Strategic SWOT Analysis Review

Upstream Biosciences Inc. (UPBS) - Financial and Strategic SWOT Analysis Review

  • $ 300
  • Company report
  • November 2014
  • by Global Data

Summary Upstream Biosciences Inc. (Upstream Biosciences) is a biotechnology company, based in Canada. The company discovers designs, develops and market drugs for the treatment of infectious diseases. ...

  • Industries : Pathology
  • Countries : Canada
Pernix Sleep, Inc. - Strategic SWOT Analysis Review

Pernix Sleep, Inc. - Strategic SWOT Analysis Review

  • $ 300
  • Company report
  • November 2014
  • by Global Data

Summary Pernix Sleep, Inc. (Pernix Sleep), formerly known as Somaxon Pharmaceuticals, Inc. is a speciality pharmaceutical company. The company conducts research and development of innovative therapeutics ...

  • Industries : Pathology
  • Countries : United States
Teva Canada Limited - Strategic SWOT Analysis Review

Teva Canada Limited - Strategic SWOT Analysis Review

  • $ 300
  • Company report
  • November 2014
  • by Global Data

Summary Teva Canada Limited (Teva Canada) is a pharmaceutical company. The company develops, produces and markets generic and branded pharmaceuticals. It offers various products for diabetes, ear infections, ...

  • Industries : Pathology
  • Countries : Canada
Advanced Medical Institute Inc. - Strategic SWOT Analysis Review

Advanced Medical Institute Inc. - Strategic SWOT Analysis Review

  • $ 300
  • Company report
  • November 2014
  • by Global Data

Summary Advanced Medical Institute Inc. (AVMD) operates through its wholly owned subsidiary AMI Australia Holdings Pty Limited (AMI Australia). The company provides treatment programs for erectile dysfunction, ...

  • Industries : Pathology
  • Countries : Australia
Green Cross Cell Corporation (031390) - Financial and Strategic SWOT Analysis Review

Green Cross Cell Corporation (031390) - Financial and Strategic SWOT Analysis Review

  • $ 300
  • Company report
  • November 2014
  • by Global Data

Summary Green Cross Cell (Green Cross), formerly Innocell Corporation, is a pharmaceutical company. The company develops immune cell treatment drugs and the storage of immune cells. It offers Immuncell-LC, ...

  • Industries : Pathology
  • Countries : South Korea

About 200 Companies

Read our Company Profiles

Pfizer Inc.

United States

Novartis Inc.

Switzerland

GlaxoSmithKline PLC

United Kingdom

GlaxoSmithKline P.L.C.

United States

Imaging Systems L.L.C.

United States

ReportLinker is an award-winning market research solution that finds, filters and organizes the latest industry data so you get all the market research you need - quickly, in one place.